- Janux Therapeutics press release (NASDAQ:JANX): Q2 GAAP EPS of -$0.55.
- Cash and cash equivalents and short-term investments: As of June 30, 2025, Janux reported cash and cash equivalents and short-term investments of $996.0 million, compared to $1.03 billion at December 31, 2024.
Janux Therapeutics GAAP EPS of -$0.55
.png)
2 hours ago
2
Related
Oil, down 5% this week, adds to losses on news of Trump-Puti...
32 minutes ago
0
Vroom GAAP EPS of -$1.65, revenue of $41.42M
2 hours ago
1
Popular
Listen to the sounds of a black hole with these NASA sonific...
2 months ago
75
Palm Springs Bombing: What We Know About Fertility Clinic Ex...
2 months ago
66
Oil futures fall as Saudi Arabia said to seek more big OPEC ...
2 months ago
49
This is the next historical period I want to see in Assassin...
2 months ago
44
UK's unemployment rate rises to 4.6% in April
1 month ago
41
English (US) · © Insaro Search Engines 2025. All rights are reserved